AGN : Analysis & Opinions

  1. Merck Up on OncoEthix Acquisition Deal, Oncology in Focus - Analyst ...

    December 19, 2014
    Merck (MRK) acquired Swiss biotech privately held company, OncoEthix, and added a promising experimental early-stage candidate, ...
  2. AstraZeneca's Lynparza Approved in EU for Ovarian Cancer - Analyst ...

    December 19, 2014
    AstraZeneca's (AZN) Lynparza was approved as a monotherapy for the maintenance treatment of adults suffering from ovarian ...
  3. Novartis Successfully Expands Signifor Label in the U.S. - Analyst ...

    December 17, 2014
    Novartis's (NVS) Signifor long-acting release was approved in the U.S. for the acromegaly indication.
  4. 3 U.S. Medical Devices Stocks That Surged in 2014 - Analyst Blog

    December 17, 2014
    The prospects of the medical devices industry have improved following a Republican victory in the midterm elections.
  5. This ETF Offers Easy Access To Big Pharma

    November 21, 2014
    Pharma investing isn't for everyone, but sector-specific ETFs, such as the iShares Dow Jones U.S. Pharmaceuticals ETF, have ...
  6. Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook

    November 18, 2014
    Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook
  7. All Quiet On The Market Front: Dow, S&P 500, Nasdaq Virtually ...

    November 12, 2014
    U.S. stocks were little changed on Wednesday in another quiet trading session due to a lack of catalysts to move stocks. ...
  8. Pharma, Biotech M&As Heat Up: Tax Inversion in Focus - Industry ...

    July 24, 2014
    Pharma, Biotech M&As Heat Up: Tax Inversion in Focus - Industry Outlook
  9. As stocks see strong headwinds, investors can take a few tips from a successful short-seller.

    Learn How To Invest Defensively From This Hedge Fund Pro

    May 21, 2014
    With the Dow Jones Industrial Average and the S&P 500 hovering near all-time highs and plenty of investors shifting to a ...
  10. Allergann (NYSE:AGN) is up almost 35% over the last three months, after experiencing a major turnaround in late 2013.

    Technical Outlook For Four Exceptionally Hot Stocks

    January 15, 2014
    These four large cap stocks are all up more than 30% in the last three months. Here's the technical outlook going forward.
  11. Yet Another Failure Has Rigel Pharmaceuticals Almost Back To ...

    August 26, 2013
    Rigel sees yet another clinical failure from its pipeline.
  12. After A Sharp Pullback, Is Allergan Pretty Enough?

    July 31, 2013
    Down on fears about generics and the pipeline, the Street may be underestimating Allergan
  13. Valeant Eyes Bausch & Lomb

    May 28, 2013
    Canadian pharmaceutical company Valeant has made a name for itself through acquisitions. On May 27 it announced that it was ...
  14. Abbott Spins Off Pharma Business - Analyst Blog

    January 3, 2013
    Abbott Laboratories (ABT) recently announced that the company has separated its research-based pharmaceuticals business by ...
  15. Allergan Third Quarter Earnings

    October 30, 2012
    Allergan (NYSE:AGN) announced its results for the most recent quarter on October 30, 2012. Allergan is a global specialty ...
  16. Valeant Works Its Mojo With Medicis

    September 7, 2012
    Valeant makes a bold but logical bid for Medicis.
  17. Allergan and Other NYSE Stocks Making Big Moves

    August 1, 2012
    After this morning's trading, the market is looking good. The Nasdaq has increased 0.1%; the S&P 500 is trading up 0.5%; ...
  18. Obagi Puts Its Problems Behind It

    May 25, 2012
    A year ago, Obagi Medical Products faced some problems in Texas that presented an investment opportunity. One year later ...
  19. 6 Overbought Stocks To Watch

    March 30, 2012
    Let's take a look at a few stocks that have recently entered overbought territory because these could be candidates for a ...
  20. Top Drug Stocks

    June 30, 2011
    Recently, three strong factors are driving investors to the drug sector.
  21. Obagi's Pitfalls Provide Investment Opportunity

    May 24, 2011
    Obagi's stock dropped 24% after announcing a 13-cent loss in its first quarter. Find out why this presents an opportunity ...
  22. Novartis Brings Alcon Into The Fold

    December 16, 2010
    Novartis closes the deal for Alcon.
  23. Allergan Winning Wall Street's Beauty Pageant

    November 3, 2010
    Allergan's earnings aren't special, but the stock is basking in Wall Street's love. Is it simply a case of lipstick on a ...
  24. Novartis Looks For 20/20 Vision With Alcon

    January 11, 2010
    The Swiss drug maker hopes to take full ownership of Alcon later in the year. Find out what it'll mean for these two companies. ...
Trading Center